Lipoprotein A (LPA) ELISA Kits

The protein encoded by LPA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. Zusätzlich bieten wir Ihnen LPA Antikörper (37) und und viele weitere Produktgruppen zu diesem Protein an.

list all ELISA KIts Gen GeneID
LPA 4018
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen

Top LPA ELISA Kits auf

Showing 10 out of 16 products:

Katalog Nr. Reaktivität Sensitivität Bereich Bilder Menge Lieferzeit Preis Details
  96 Tests 2 bis 3 Tage
Maus 0.46 ng/mL 1.56 ng/mL - 100 ng/mL Typical Standard Curve 96 Tests 15 bis 17 Tage
Meerschweinchen 1.0 ng/mL 5.0-100 ng/mL   96 Tests 15 bis 18 Tage
Kaninchen 1.0 ng/mL 5.0-100 ng/mL   96 Tests 15 bis 18 Tage
Ratte 1.0 pg/mL 250-5000 pg/mL   96 Tests 15 bis 18 Tage
Affe 1.0 pg/mL 250-5000 pg/mL   96 Tests 15 bis 18 Tage
Hund 1.0 ng/mL 5.0-100 ng/mL   96 Tests 15 bis 18 Tage
  96 Tests 15 bis 18 Tage
  96 Tests 15 bis 18 Tage
Rind (Kuh)
  96 Tests 15 bis 18 Tage

Weitere ELISA Kits für LPA Interaktionspartner

Human Lipoprotein A (LPA) Interaktionspartner

  1. Elevated serum lipoprotein(a) level is an independent predictor of cardiac and cardiovascular events in the coronary artery disease patients.[meta-analysis]

  2. We show that PCSK9 levels increase with age in ART children, indicating a gradual deterioration of lipidemic profile that could lead to increased cardiovascular risk. Moreover, our results indicate that ART method may be of importance given that classic IVF is associated with higher levels of Lp(a).

  3. Lp(a) was only a marker for coronary artery disease in patients with familial hypercholesterolemia.

  4. Circulating Lp(a) is not prospectively associated with future venous thromboembolism risk.

  5. Stable outpatients with symptomatic artery disease and Lp(a) levels >30mg/dL were at a 5-fold higher risk for subsequent myocardial infarction, stroke or limb amputation. Those with levels >50mg/dL were at an over 10-fold higher risk.

  6. In patients with potential familial hypercholesterolemia, positive correlations between concentrations of Lp(a) and PCSK9, as well as of Lp(a)-PCSK9 plasma complex with large subfractions of intermediate and low-density lipoproteins (IDL-1 and LDL-C), were determined by the low molecular weight apo(a) phenotype.

  7. Lp(a) concentration, but not apo(a) isoform size, is independently associated with angiographic extent and severity of coronary artery disease, but not carotid artery plaque.

  8. potential role for Lp(a) as a possible risk marker useful to stratify, among bicuspid aortic valve stenosis patients

  9. Lp(a) molar/mass ratios are threshold, method, and isoform dependent

  10. Meta-analysis: Genetic variations at the LPA locus are associated with CHD events during statin therapy independently of the extent of low-density lipoprotein cholesterol lowering.

  11. Lp(a) accelerates progression of atherosclerosis in these individuals, thereby contributing to their increased ASCVD risk

  12. Proinflammatory interleukin 1 (IL-1(+)) genotypes modulate the risk of Lp(a) long-term cardiovascular disease (CVD) events and coronary artery disease (CAD).

  13. The autors results confirm the association between LPA SNPs rs10455872 and rs3798220 with AS and demonstrated that individuals with 2 risk alleles have a 2-fold or greater odds of developing AS.

  14. The LPA 9p21 locus was associated with risk of aortic valve stenosis.

  15. High lipoprotein(a) levels were associated with a higher incidence of major adverse limb events after endovascular treatment for patients with aortoiliac lesions.

  16. In a multiethnic sample, Lp(a)-related risks of heart failure were only evident in white participants.

  17. High plasma lipoprotein a levels accelerated the progression of atherosclerosis in end-stage renal disease through lipoprotein a accumulation in the arteries.

  18. The population differences in Lp(a) concentrations between Finnish and Central European populations originate not only from a different LPA isoform distribution but suggest the existence of novel functional variation in the small-isoform range.

  19. Elevated lipoprotein(a) concentrations were independently associated with an increased risk of abdominal aortic aneurysms.

  20. Lp(a) seems to be an independent risk factor for acute coronary syndromes in individuals <45 years, and high Lp(a) levels increase by approximately 3folds the risk for ACS. The association is preserved but is less in middle-aged individuals (45-60 years) and is abolished >60 years.

LPA Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The encoded protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the encoded protein contains 2-43 copies of kringle-type domains. The allele represented here contains 15 copies of the kringle-type repeats and corresponds to that found in the reference genome sequence.

Genbezeichner und Symbole assoziert mit Lipoprotein A (LPA) ELISA Kits

  • lipoprotein(a) (LPA) Antikörper
  • coagulation factor II, thrombin S homeolog (f2.S) Antikörper
  • AK38 Antikörper
  • APOA Antikörper
  • LP Antikörper
  • LPA Antikörper
  • MGC82169 Antikörper

Bezeichner auf Proteinebene für Lipoprotein A (LPA) ELISA Kits

antiangiogenic AK38 protein , apo(a) , apolipoprotein(a) , lp(a) , lipoprotein, Lp(a) , apolipoprotein(a)-like

4018 Homo sapiens
446352 Xenopus laevis
463116 Pan troglodytes
100439959 Pongo abelii
Ausgewählte Anbieter für LPA (LPA) ELISA Kits
Haben Sie etwas anderes gesucht?